Dr Beier will use the funding to explore personalised treatment approaches to heart attack stenting.

“Heart disease is the most common cause of death globally and kills one Australian every 27 minutes. Narrowed coronary arteries can be treated by implanting a stent – a mesh metal tube which reopens the vessel. But up to 160,000 stent patients worldwide develop complications – from blood clots to unwanted tissue growth,” Dr Beier said.

“My research will explore a personalised treatment approach, where individual shape differences are accounted for. These shapes can be explored by using the latest analysis, blood flow simulations and 3D soft printing,” Dr Beier continued.